allulose glp 1 effect 2026 Review: What It Is and How To Use It Right GLP-1: Genetic Variants Related to

Updated epidemiology of gastrointestinal cancers in East Asia

DRP-104 has been tested in the NCT 04471415 clinical trial to assess its preliminary safety and efficacy as a monotherapy or in combination with anti-PD-L1 immunotherapy (atezolizumab) in patients with advanced solid tumors such as PCa

Integration of bulk/scRNA-seq and multiple machine learning algorithms identifies PIM1 as a biomarker associated with cuproptosis and ferroptosis in abdominal aortic aneurysm

Consequently, mSOD1 Tregs contributed to slowing down the progression phase in ALS mice and may offer a novel therapeutic option for ALS patients in the stable disease phase [28, 29]